Literature Review

All posts tagged with “Clinical News | Disease Specific.”



Top ten tips all palliative care clinicians should know about Anorexia Nervosa and eating disorder care

06/13/26 at 03:15 AM

Read More

The clinical relevance of sleep disturbance ("insomnia") in patients with advanced cancer receiving palliative care: A scoping review

06/13/26 at 03:10 AM

The clinical relevance of sleep disturbance ("insomnia") in patients with advanced cancer receiving palliative care: A scoping reviewSupportive Care in Cancer; by Shauna Munir, Eva Jones, Faith Precious Omeokwe, Andrew Neil Davies; 5/26Sleep disturbance ("insomnia") is common in patients with advanced cancer receiving specialist palliative care. The studies highlight that sleep disturbance is associated with a range of physical symptoms (e.g. fatigue, drowsiness), a variety of psychological problems (e.g. anxiety, depression), impaired quality of life, and reduced overall survival. Sleep disturbance is an "orphan" symptom, and the results of this scoping review suggest that it deserves much greater attention. Indeed, healthcare professionals should screen all palliative care patients for the problem and, when identified, perform a thorough assessment and initiate an appropriate treatment.

Read More

Managing cancer-related pain in patients receiving long-acting buprenorphine for opioid use disorder

06/13/26 at 03:05 AM

Read More

Challenging case: Navigating end-of-life in neuro-inclusive cancer care

06/06/26 at 03:35 AM

Read More

Supporting complex decision making in dysphagia management within palliative rehabilitation

06/06/26 at 03:30 AM

Read More

Social risk factors and disparities in advanced cardiovascular-kidney-metabolic syndrome

06/06/26 at 03:25 AM

Read More

Implications of Medicare negotiation and most-favored-nation pricing for cancer medicine costs

06/06/26 at 03:10 AM

Read More

[Italy] Understanding the evolving role of early palliative care in myelodysplastic syndromes: A 2026 narrative review

06/06/26 at 03:05 AM

[Italy] Understanding the evolving role of early palliative care in myelodysplastic syndromes: A 2026 narrative reviewAnnals of Hematology; by Pasquale Niscola, Valentina Gianfelici, Marco Giovannini, Carla Mazzone, Maria Ilaria Del Principe; 5/26Myelodysplastic Syndromes/Neoplasms (MDS) are a heterogeneous group of blood cancers characterized by a broad spectrum of symptoms and varying impacts on quality of life (QoL). Although the integration of early PC care has long been recognized as an essential part of comprehensive management for patients with solid tumors, experience in the context of MDS is still limited. However, symptom control, QoL, advanced care planning goals, the reduction of aggressive therapies, intensive care use, including intubation before death, and resource use in the end-of-life (EOL) phase are critical issues that are enhanced through early PC in MDS management. Additionally, integrating standard hematological measures with early PC leads to fewer visits and hospital admissions near the EOL, particularly during the last 30 days. Moreover, patients with early PC die at home or in hospice care at a rate nearly in line with their preferences.

Read More

Symptom-monitoring app helps patients with advanced cancer maintain quality of life

06/04/26 at 03:00 AM

Symptom-monitoring app helps patients with advanced cancer maintain quality of life The ASCO Post; by The ASCO Post Staff; 6/2/26 Use of a mobile app for proactive symptom monitoring helped patients with advanced cancer who were no longer receiving active anticancer treatment maintain their quality of life and reduced hospital utilization, according to findings from a randomized controlled trial presented at the 2026 ASCO Annual Meeting. The study evaluated SUPPORT+, a digital symptom-monitoring platform designed for patients receiving palliative care. The app sends weekly automated reminders prompting patients—or their caregivers—to complete a brief questionnaire about physical and emotional symptoms. Based on responses, the app provides self-management recommendations for mild or moderate symptoms and automatically alerts palliative care nurses when severe or worsening symptoms are reported. Nurses then follow up with patients through the app or by telephone.

Read More

Early palliative integration for heart failure

06/01/26 at 03:00 AM

Early palliative integration for heart failure Medscape; by Karel De Pourcq, PhD; 5/27/26 ... Chronic conditions such as heart failure often bring relentless symptoms, repeated hospital admissions, and deep emotional and social effects for patients and their families. Bringing a palliative perspective into care widens the focus beyond disease-directed treatments to include ongoing symptom relief, emotional support, and help for overburdened caregivers. It also promotes early, shared planning about treatment intensity — deciding when worsening episodes can be managed at home vs when hospitalization is needed — and clarifying care goals as the illness progresses.

Read More

Ketamine for depression in serious illness: Evidence, safety, and practical approaches

05/30/26 at 03:10 AM

Ketamine for depression in serious illness: Evidence, safety, and practical approachesJournal of Pain & Symptom Management; by Paul Noufi, Joshua B. Borris, Danielle Chammas, Cara L. McDermott, Nneka N. Ufere, Jason A. Webb, Daniel Shalev; 4/26Patients with serious illness and short prognoses often experience depression and suicidal ideation. Traditional antidepressants are limited by delayed onset, creating a need for rapidly acting therapies. Ketamine and esketamine [nasal spray] offer the strongest evidence among rapid-acting antidepressants and may be preferred when urgent symptom relief is needed. However, rigorous psychiatric trials in serious illness are lacking. Clinicians should consider prognosis, access to Risk Evaluation and Mitigation Strategies-certified esketamine programs or equivalent regulatory frameworks outside the US, and the need for an appropriate maintenance regimen when integrating ketamine into palliative care depression management.

Read More

Real-world experience with initiating buprenorphine in opioid tolerant patients with cancer pain

05/30/26 at 03:05 AM

Read More

[Turkey] A mobile health application for controlling symptoms of chronic obstructive pulmonary disease: A randomised controlled trial

05/30/26 at 03:05 AM

Read More

Pediatric neuropalliative medicine clinic: Five‐year data characterizing a novel model of outpatient care

05/23/26 at 03:35 AM

Read More

Potential adjunctive role of osteopathic manipulative medicine in the management of cancer-related bone pain: A narrative review

05/23/26 at 03:30 AM

Potential adjunctive role of osteopathic manipulative medicine in the management of cancer-related bone pain: A narrative reviewCureus; by Ambrose Loc T. Ngo, Niki Gharavi Alkhansari, Chi Pham, Hong Nguyen, Monica Rubi, David Tanner; 4/26Osteopathic manipulative medicine (OMM) is known for its therapeutic potential on the musculoskeletal system, and its emerging role and potential benefits in oncology care are gaining attention. Patients with primary and metastatic bone cancer tend to experience pain, restricted movement, and lower quality of life due to the pathology and its treatment. This narrative review examines the mechanistic rationale and available clinical evidence supporting the use of OMM in the management of pain and functional impairment among patients with bone malignancies. Limited clinical studies suggest that select OMM techniques, including myofascial release (MFR), gentle soft tissue methods, and lymphatic approaches, may contribute to improvements in pain perception, mobility, and fatigue in oncology populations.

Read More

“It felt like throwing in the towel”: Family caregiver perspectives on end-of-life decision making in Chronic Obstructive Pulmonary Disease

05/23/26 at 03:20 AM

Read More

Palliative care in rheumatology: Perspectives of rheumatologists and palliative care clinicians across the United States

05/23/26 at 03:05 AM

Read More

Palliative care intervention for patients with end-stage liver disease-A cluster randomized clinical trial

05/23/26 at 03:00 AM

Palliative care intervention for patients with end-stage liver disease-A cluster randomized clinical trialJAMA Internal Medicine; by Manisha Verma, Victor Navarro, Andrzej Kosinski, Tamar Taddei, Richard Kalman, A. Sidney Barritt, Simona Jakab, Marina Serper, Eric Orman, Maya Balakrishnan, Mina Rakoski, Don Rockey, Kristel Hunt, Roniel Cabrera, Ayse Aytaman, Binu John, Gyorgy Baffy, Rohit Nathan, Elliot Tapper, Marina Roytman, Brendan McGuire, Nicholas Hoppmann, Christopher Woodrell, Marie Bakitas, Yang Yue, Bryce Reeve, Li Lin, Rebecca Tantala, Michael Volk; 4/26Palliative care improves quality of life (QoL) in advanced illnesses, but data in end-stage liver disease (ESLD) are limited. It is unknown whether palliative care delivered by hepatologists is effective when compared with palliative care specialists. This cluster trial found that palliative care delivered by trained hepatologists was comparable with palliative care delivered by palliative care specialists in improving QoL in patients with ESLD and was associated with greater improvement in patient satisfaction, demonstrating the effectiveness among enrolled patients.Assistant Editor's note: That's the beauty of palliative care. It can be layered upon many other specialties and sub-specialties and utilized by a variety of health care disciplines. The science of palliative care, the skill and knowledge base involved, is adaptable and valuable for almost anyone working in direct patient care in many different health care settings.

Read More

From lacking to linking: A call for inclusion of pediatric palliative care in national cancer data ecosystems

05/16/26 at 03:40 AM

Read More

End-of-life care patterns for cholangiocarcinoma in the United States: A 26-year analysis of home and hospice deaths by demographic, regional, and urbanization factors

05/16/26 at 03:35 AM

Read More

Trends in preferred place of death among patients with bladder cancer in the United States, 2000 to 2020

05/16/26 at 03:30 AM

Trends in preferred place of death among patients with bladder cancer in the United States, 2000 to 2020Palliative & Supportive Care; by Manas Pustake, Atharva Railkar, Mohammad Arfat Ganiyani, Atulya Aman Khosla, Avi Harisingani, Hanzala Jehangir, Mostafa Eysha, Divya Samat, Taha Hassan, Rohan Garje; 4/26Understanding trends in end-of-life care for bladder cancer patients is essential in improving palliative care planning. This study analyzes trends in preferred place of death among bladder cancer patients in the United States from year 2000 to 2020. Black individuals had significantly lower odds of hospice use than White patients ... and hospice use increased annually by an average of 13.4% ...  Interestingly, younger individuals were more likely to die in hospice compared to those aged 85 years or older, though the odds decreased with age. The results indicate that utilization of hospice care and home-based end-of-life care have risen in prominence though disparities are present across racial and regional groups.

Read More

Self-reliance in a fractured health care system: A qualitative study of rural Oklahoman’s experiences managing cancer pain during the opioid epidemic

05/09/26 at 03:30 AM

Read More

Considerations and recommendations for palliative care management in the geriatric trauma population

05/09/26 at 03:20 AM

Read More

[Canada] Palliative care in multiple sclerosis

05/09/26 at 03:05 AM

[Canada] Palliative care in multiple sclerosisContinuum; by Penelope Smyth, Janis M. Miyasaki; 4/26This article reviews palliative care concepts valuable to neurologists caring for people with multiple sclerosis (MS), describes the three stages of palliative principles in care delivery, and suggests triggers to refer for specialized palliative care interventions. Advances in disease-modifying therapies have extended life expectancy and reduced disability progression in patients with multiple sclerosis. However, palliative care remains underutilized in addressing persistent symptoms, care partner burden, and psychosocial challenges. Palliative care strategies in MS can be divided into three stages: early-stage palliative care needs and screening after diagnosis; midstage palliative care needs, including symptom management and quality-of-life optimization; and late-stage palliative care needs, including managing severe MS and end-of-life care. Additional foci of specialist palliative care may include end-of-life care, advance care planning, care partner support, and patient consideration of medically assisted death. 

Read More

Assessing and Listening to Individual Goals and Needs (ALIGN) versus enhanced usual care for hospitalized older patients with cancer discharged to skilled nursing facilities: Protocol for a pilot randomized controlled trial

05/09/26 at 03:05 AM

Read More